Marinus Pharmaceuticals reported $247M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Amgen AMGN:US USD 140.14B 19.78B
Aptinyx Inc APTX:US USD 25M 13M
Biogen BIIB:US USD 39.1B 9.24B
Eisai 4523:JP JPY 2.3T 600.25B
Enanta Pharmaceuticals ENTA:US USD 1.08B 96M
Esperion Therapeutics ESPR:US USD 446M 45M
Gilead Sciences GILD:US USD 77.36B 170M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Intra Cellular Therapies ITCI:US USD 4.41B 977M
Marinus Pharmaceuticals MRNS:US USD 247M 67M
Minerva Neurosciences NERV:US USD 49M 31M
Neurocrine Biosciences NBIX:US USD 10.16B 841M
Ptc Therapeutics PTCT:US USD 3.61B 742M
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Supernus Pharmaceuticals SUPN:US USD 1.83B 285M
UCB UCB:BB EUR 15.68B 3.83B
Vertex Pharmaceuticals VRTX:US USD 74.3B 2.16B
YTE INCY:US USD 14.82B 2.01B